SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Gundlach Andrew | Director | 2026-08-26 | Open-market buy | 2500 | $605K |
| Gundlach Andrew | Director | 2026-08-26 | Open-market buy | 2500 | $605K |
| Gundlach Andrew | Director | 2026-08-25 | Open-market buy | 2500 | $599K |
| Gundlach Andrew | Director | 2026-08-25 | Open-market buy | 2500 | $599K |
| LOPEZ DENNIS G | Director | 2026-08-20 | Grant/award | 73 | $17K |
| Mitra Shankh | CEO, Director | 2026-06-26 | Gift | 3852 | $0 |
| Mitra Shankh | CEO, Director | 2026-05-31 | Grant/award | 17 | $3K |
| Mitra Shankh | CEO, Director | 2026-05-27 | Gift | 162 | $0 |
| LOPEZ DENNIS G | Director | 2026-05-21 | Grant/award | 63 | $14K |
| BACON KENNETH J | Director | 2026-05-01 | C | 2627 | $0 |
| DeSalvo Karen B | Director | 2026-02-26 | Grant/award | 1056 | $0 |
| LOPEZ DENNIS G | Director | 2026-02-26 | Grant/award | 1787 | $0 |
| Rivera Sergio | Director | 2026-02-26 | Grant/award | 1056 | $0 |
| Spisso Johnese | Director | 2026-02-26 | Grant/award | 1056 | $0 |
| Mcqueen Matthew Grant | Chief Legal Officer | 2026-02-13 | Gift | 541 | $0 |
| Fieweger Joshua | SVP, Chief Accounting Officer | 2026-01-15 | Tax withholding | 124 | $23K |
| LOPEZ DENNIS G | Director | 2025-12-31 | Grant/award | 57 | $0 |
| McHugh Timothy | Co-President and CFO | 2025-12-16 | Gift | 500 | $0 |
| Burkart John F. | Vice Chairman and COO | 2025-11-28 | Grant/award | 39 | $5K |
| Chaudhri Nikhil | Co-President and CIO | 2025-11-28 | Grant/award | 31 | $4K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
The company's risk profile has materially worsened across strategic, regulatory, and operational dimensions, driven by two large portfolio transactions and a wave of newly disclosed legislative threats. The OBBBA's projected ~$1 trillion in federal healthcare spending cuts—including mandatory 10% annual Medicaid reimbursement reductions starting 2028—represents the most severe single escalation, directly pressuring operator and tenant revenue. Simultaneously, the $7.2B outpatient divestiture and £5.2B U.K. seniors housing acquisition introduce concentrated execution, market, and geopolitical risks that compound an already broadening risk picture.
5 company-specific · 4 common-mode
New disclosure of $7.2B outpatient portfolio divestiture with material execution and market risks. Substantive strategic transaction requiring investor awareness.
Divestitures may materially affect our financial condition, results of operations or cash flows We continually evaluate the performance of different facets of our business in connection with our…
New disclosure of divestiture risk materially affecting financial condition, results, or cash flows. Represents newly escalated strategic risk.
Risks Arising from Our Business: Our business model and the operations of our business involve risks, including those related to: • operational and legal risks with respect to our properties; •…
New disclosure of £5.2 billion U.K. seniors housing portfolio acquisition materially escalates geographic and geopolitical risk exposure beyond prior year's general language.
Our investments in and acquisitions of healthcare and seniors housing properties may be unsuccessful or fail to meet our expectations We have made and expect to continue to make significant…
Added explicit language that climate change and economic conditions are directly affecting insurance availability and premiums, and company may self-insure more, absorbing greater losses.
Our tenants, operators and managers may not have the necessary insurance coverage to insure adequately against losses We maintain or require our tenants, operators and managers to maintain…
New disclosure of data analytics services and cross-facility data aggregation practices under HIPAA, introducing specific operational and compliance liability risks not previously disclosed.
Evolving privacy regulations could expose our business to reputational harm and losses We are subject to continuously evolving and developing laws and regulations in the U.S. and abroad that concern…
New disclosure of legislative threats to REIT ownership and healthcare property investment, including potential restrictions on REIT tax benefits and transaction approvals. Material to REIT business model.
We may be adversely affected by changing laws and regulation, including restrictions related to REIT ownership The laws and regulations that apply to us and our operators, managers and tenants are…
New disclosure of OBBBA projected to decrease federal healthcare spending by ~$1 trillion through Medicaid cuts and Medicare changes, materially escalating reimbursement risk.
The requirements of, or changes to, governmental reimbursement programs, such as Medicare, Medicaid or government funding, could have a material adverse effect on our obligors’ liquidity, financial…
New specific regulatory risk disclosed: OBBBA provision requiring 10% annual Medicaid reimbursement cuts starting 2028, materially escalating revenue pressure on operators and tenants.
Decreases in our operators’ or tenants’ revenues or increases in our operators’ or tenants’ expenses, including as a result of increased labor costs, could affect their ability to make…
Escalated climate risk disclosure: added explicit mention of divergent state regulations, renewable energy transition mandates, net-zero targets, and competitive harm from failing resilience standards—material new regulatory and operational burdens.
We may experience losses caused by severe weather conditions, natural disasters or the physical effects of climate change, which could result in an increase in our or our tenants’ cost of…
Welltower entered into an at-the-market (ATM) equity distribution agreement on July 28, 2026, authorizing the issuance and sale of up to $7.5 billion in common stock through multiple sales agents. The filing also discloses a resale prospectus supplement for 261,753 shares issued as consideration for a lease amendment. ATM offerings represent a dilutive issuance of equity securities that would materially affect investor assessment of share dilution and capital structure, fitting the dilutive_issuance category.
View raw filing on EDGAR →Welltower Inc. issued a press release on July 27, 2026 announcing operating results for the second quarter ended June 30, 2026. The disclosure includes key financial metrics such as net income per diluted share ($0.61), normalized FFO per diluted share ($1.60, up 25% year-over-year), portfolio same-store NOI growth (15.5%), and revised full-year guidance for net income and normalized FFO. This is a standard quarterly earnings release with financial results and forward guidance, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →Welltower OP LLC issued C$750 million of 3.850% Notes due 2031 and C$400 million of 4.150% Notes due 2033 on July 13, 2026, pursuant to an underwriting agreement. This is a creation of new direct financial obligations totaling C$1.15 billion, with the net proceeds intended for debt repayment and investment in healthcare and seniors housing properties. The disclosure clearly describes the issuance terms, interest rates, maturity dates, and use of proceeds, which are hallmarks of a material debt issuance event.
View raw filing on EDGAR →Welltower announced an increase in its quarterly common stock dividend from an implied prior level to $0.85 per share, effective Q2 2026. While dividend announcements are material to investors and affect total shareholder return expectations, this disclosure does not fit cleanly into the standard taxonomy categories (earnings_release, exec_compensation, etc.). The announcement is a capital allocation decision rather than a financial result, executive action, or compensation arrangement, making "other_material" the most appropriate classification.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Welltower's 2026 Annual Meeting of Shareholders held on May 21, 2026, including voting outcomes on three proposals: election of nine directors, ratification of Ernst & Young LLP as auditor, and an advisory vote on named executive officer compensation. The filing explicitly states that the compensation proposal "was not approved," which is material to investors as it signals shareholder dissatisfaction with executive pay arrangements. The detailed vote tallies for each director and proposal are the core content of this 8-K section.
View raw filing on EDGAR →